亚太地区临床试验成像市场预测至 2028 年 - COVID-19 影响和区域分析 - 按模态 [断层扫描、磁共振成像 (MRI)、超声波、正电子发射断层扫描 (PET)、X 射线、超声心动图等] 提供（操作成像服务、成像软件、读取分析服务、试验设计和咨询服务等）和最终用户 [合同研究组织 (CRO)、制药和生物技术公司、学术和研究机构等]
No. of Pages: 134 | Report Code: BMIRE00028597 | Category: Life Sciences
No. of Pages: 134 | Report Code: BMIRE00028597 | Category: Life Sciences
人工智能 (AI) 有助于有效的数据收集和管理，从而为参与药物开发的生命科学公司带来游戏规则改变者过程。人工智能的采用推动了收集临床试验数据并减少对手动操作的依赖的创新方式。下面的案例可以很好地说明这一点：阿斯利康收集了超过 100,000 名同意患者的肿瘤学数据，包括临床和影像数据，用于不同的临床研究。为了改变肿瘤学数据馈送的过程，该团队采用复杂的数据集，通过“FAIR”实现数据的可访问性、互操作性和可重用性。这种集成使得从特定临床试验和项目中收集的数据可以在公司的药物开发团队中访问，同时符合数据保护法。此外，阿斯利康还与 Tempus 等外部公司合作，利用真实数据并代表该地区的患者。这种战略伙伴关系/无机策略提供了有关医疗保健系统中患者结果的重要证据，而无需透露数据集中临床试验参与者的身份。因此，人工智能在临床试验数据处理中的日益应用可能会在未来几年促进亚太地区临床试验成像市场的增长。
亚太地区临床试验成像市场分为中国、日本、印度、澳大利亚、韩国和亚太其他地区。 2022年，中国将占据最大的市场份额，预计在预测期内复合年增长率最高，达到8.6%。这一增长是由于成熟的制药公司、制药和生物制药公司研发支出的增加、成本降低导致的临床试验激增、成熟的医疗保健技术、主要参与者推出创新产品以及有利的条件监管政策。中国拥有全球第二大医药市场。中国人口过多，加上各种传染性和非传染性疾病的增加，是推动中国制药公司发展的主要动力。
亚太地区临床试验成像市场细分
亚太地区临床试验成像市场根据模式、产品、最终用户和国家/地区进行细分.
根据模式，亚太临床试验成像市场分为断层扫描、磁共振成像 (MRI)、超声波、正电子发射断层扫描 (PET)、X 射线、超声心动图等。断层扫描细分市场在 2023 年占据最大市场份额。
根据产品类型，亚太地区临床试验成像市场分为操作成像服务、成像软件、读取分析服务、试验设计和咨询服务等。运营成像服务细分市场在 2023 年占据最大市场份额。
根据最终用户，亚太地区临床试验成像市场分为合同研究组织 (CRO)、制药以及生物技术公司、学术和研究机构等。合同研究组织 (CRO) 细分市场在 2023 年占据最大的市场份额。
根据国家/地区，市场分为中国、日本、印度、澳大利亚、南非韩国以及亚太其他地区。 2023 年，中国在市场份额中占据主导地位。
Calyx Inc、eResearch Technology Inc、ICON PLC、IXICO plc、Medical Metrics Inc、Radiant Sage LLC、VIDA Diagnostics Inc 、和 WCG Clinical Inc 是亚太临床试验成像市场的领先公司。
Strategic insights for Asia Pacific Clinical Trial Imaging involve closely monitoring industry trends, consumer behaviours, and competitor actions to identify opportunities for growth. By leveraging data analytics, businesses can anticipate market shifts and make informed decisions that align with evolving customer needs. Understanding these dynamics helps companies adjust their strategies proactively, enhance customer engagement, and strengthen their competitive edge. Building strong relationships with stakeholders and staying agile in response to changes ensures long-term success in any market.
| Report Attribute | Details |
|---|---|
| Market size in 2023 | US$ 373.46 Million |
| Market Size by 2028 | US$ 553.11 Million |
| Global CAGR (2023 - 2028) | 8.2% |
| Historical Data | 2021-2022 |
| Forecast period | 2024-2028 |
| Segments Covered |
By 模式
|
| Regions and Countries Covered | 亚太地区
|
| Market leaders and key company profiles |
The regional scope of Asia Pacific Clinical Trial Imaging refers to the geographical area in which a business operates and competes. Understanding regional nuances, such as local consumer preferences, economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved regions or adapting their offerings to meet regional demands. A clear regional focus allows for more effective resource allocation, targeted marketing, and better positioning against local competitors, ultimately driving growth in those specific areas.
The Asia Pacific Clinical Trial Imaging Market is valued at US$ 373.46 Million in 2023, it is projected to reach US$ 553.11 Million by 2028.
As per our report Asia Pacific Clinical Trial Imaging Market, the market size is valued at US$ 373.46 Million in 2023, projecting it to reach US$ 553.11 Million by 2028. This translates to a CAGR of approximately 8.2% during the forecast period.
The Asia Pacific Clinical Trial Imaging Market report typically cover these key segments-
The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the Asia Pacific Clinical Trial Imaging Market report:
The Asia Pacific Clinical Trial Imaging Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:
The Asia Pacific Clinical Trial Imaging Market report is valuable for diverse stakeholders, including:
Essentially, anyone involved in or considering involvement in the Asia Pacific Clinical Trial Imaging Market value chain can benefit from the information contained in a comprehensive market report.
Office No. 1011, First floor, Farena Corporate Park, Magarpatta-Mundhwa road, Pune - 411028, Maharashtra, India
US:+16467917070
sales@businessmarketinsights.com
Get Free Sample For Asia Pacific Clinical Trial Imaging Market
